{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:04:27Z","timestamp":1776690267215,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T00:00:00Z","timestamp":1273536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11307-010-0328-7","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T20:41:41Z","timestamp":1273524101000},"page":"32-42","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of Free Dye in Solutions of Dual-Labeled Antibody Conjugates for In Vivo Molecular Imaging"],"prefix":"10.1007","volume":"13","author":[{"given":"Melissa B.","family":"Aldrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XueJuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunkuk","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton V.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Sevick-Muraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,11]]},"reference":[{"issue":"3","key":"328_CR1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1148\/radiol.2463070962","volume":"246","author":"EM Sevick-Muraca","year":"2008","unstructured":"Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blanchard DK, Fisher RE, Chiang SB, Elledge R, Mawad ME (2008) Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 246(3):734\u2013741","journal-title":"Radiology"},{"issue":"1","key":"328_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.copbio.2009.01.009","volume":"20","author":"JC Rasmussen","year":"2009","unstructured":"Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM (2009) Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 20(1):74\u201382","journal-title":"Curr Opin Biotechnol"},{"key":"328_CR3","unstructured":"Meyers CLF, Meyers DJ (2008) Thin-layer chromatography. In: Curr Protoc Nucleic Acid Chem. Wiley, 34:A.3D.1\u2013A.3D.13"},{"issue":"2","key":"328_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-007-9656-y","volume":"109","author":"B Dhesy-Thind","year":"2008","unstructured":"Dhesy-Thind B, Pritchard KI, Messersmith H, O\u2019Malley F, Elavathil L, Trudeau M (2008) HER2\/neu in systemic therapy for women with breast cancer: a systematic review. Breast Cancer Res Treat 109(2):209\u2013229","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"328_CR5","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s00018-004-4277-7","volume":"61","author":"S Menard","year":"2004","unstructured":"Menard S, Casalini M, Campiglio SM, Pupa SM, Tagliabue E (2004) Role of HER2\/neu in tumor progression and therapy. Cell Mol Life Sci 61(23):2965\u20132978","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"328_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/157488707780599375","volume":"2","author":"R Nanda","year":"2007","unstructured":"Nanda R (2007) Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions. Rev Recent Clin Trials 2(2):111\u2013116","journal-title":"Rev Recent Clin Trials"},{"issue":"1","key":"328_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-007-0008-2","volume":"8","author":"A Lin","year":"2007","unstructured":"Lin A, Rugo HS (2007) The role of trastuzumab in early stage breast cancer: current data and treatment recommendations. Curr Treat Options Oncol 8(1):47\u201360","journal-title":"Curr Treat Options Oncol"},{"issue":"6 Suppl 18","key":"328_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/sonc.2001.29710","volume":"28","author":"GN Hortobagyi","year":"2001","unstructured":"Hortobagyi GN (2001) Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer. Semin Oncol 28(6 Suppl 18):43\u201347","journal-title":"Semin Oncol"},{"issue":"5 Suppl 16","key":"328_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/sonc.2001.28553","volume":"28","author":"SC Wang","year":"2001","unstructured":"Wang SC, Hung MC (2001) HER2 overexpression and cancer targeting. Semin Oncol 28(5 Suppl 16):115\u2013124","journal-title":"Semin Oncol"},{"issue":"10","key":"328_CR10","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.89.10.4285","volume":"89","author":"P Carter","year":"1992","unstructured":"Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shepard HM (1992) Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci USA 89(10):4285\u20134289","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"328_CR11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10147-006-0575-4","volume":"11","author":"E Tokunaga","year":"2006","unstructured":"Tokunaga E, Oki E, Nishida K, Koga T, Egashira A, Morita M, Kakeji Y, Maehar Y (2006) Trastuzumab and breast cancer: developments and current status. Int J Clin Oncol 11(3):199\u2013208","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"328_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10637-005-2899-8","volume":"23","author":"CH Yeon","year":"2005","unstructured":"Yeon CH, Pegram MD (2005) Anti-erB-2 antibody trastuzumab in the treatment of HER2-amplified cancer. Invest New Drugs 23(5):391\u2013409","journal-title":"Invest New Drugs"},{"issue":"15","key":"328_CR13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/jnci\/93.15.1141","volume":"93","author":"R Simon","year":"2001","unstructured":"Simon R, Nocito A, Hubscher T, Bucher C, Torhorst J, Schraml P, Bubendorf L, Mihatsch MM, Moch H, Wilber K, Schotzau A, Kononen J, Sauter G (2001) Patterns of HER-2\/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 93(15):1141\u20131146","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"328_CR14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/1097-0142(197506)35:6<1487::AID-CNCR2820350602>3.0.CO;2-E","volume":"35","author":"SE Order","year":"1975","unstructured":"Order SE, Bloomer WD, Jones AG, Kaplan WD, Davis MA, Adelstein SJ, Hellman S (1975) Radionuclide immunoglobulin lymphangiography: a case report. Cancer 35(6):1487\u20131492","journal-title":"Cancer"},{"issue":"6","key":"328_CR15","first-page":"1600","volume":"49","author":"JJ Tjandra","year":"1989","unstructured":"Tjandra JJ, Russell IS, Collins JP, Andrews JT, Lichtenstein M, Binns D, McKenzie IF (1989) Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer. Cancer Res 49(6):1600\u20131608","journal-title":"Cancer Res"},{"issue":"8 Pt. 2","key":"328_CR16","first-page":"2997","volume":"40","author":"FH DeLand","year":"1980","unstructured":"DeLand FH, Kim EE, Goldenberg DM (1980) Lymphoscintigraphy with radionuclide-labeled antibodies to carcinoembryonic antigen. Cancer Res 40(8 Pt. 2):2997\u20133000","journal-title":"Cancer Res"},{"issue":"3","key":"328_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000658-198609000-00002","volume":"204","author":"MT Lotze","year":"1986","unstructured":"Lotze MT, Carrasquillo JA, Weinstein JN, Bryant GJ, Perentesis P, Reynolds JC, Matis LA, Eger RR, Keenan AM, Hellstrom I, Hellstrom K, Larson SM (1986) Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection. Ann Surg 204(3):223\u2013235","journal-title":"Ann Surg"},{"issue":"2","key":"328_CR18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1148\/radiology.161.2.3763912","volume":"161","author":"BL Engelstad","year":"1986","unstructured":"Engelstad BL, Spitler LE, Del Rio MJ, Ramos EC, Rosendorf LL, Reinhold CE, Khentigan A, Huberty JP, Corpuz SW, Lee HM, Okerlund MD, Hattner RS, Scannon PJ (1986) Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody. Radiology 161(2):419\u2013422","journal-title":"Radiology"},{"issue":"1","key":"328_CR19","first-page":"34","volume":"28","author":"WB Nelp","year":"1987","unstructured":"Nelp WB, Eary JR, Jones RF, Hellstrom KE, Hellstrom I, Beaumier PL, Krohn KA (1987) Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. J Nucl Med 28(1):34\u201341","journal-title":"J Nucl Med"},{"issue":"22","key":"328_CR20","first-page":"6093","volume":"47","author":"AM Keenan","year":"1987","unstructured":"Keenan AM, Weinstein JN, Carrasquillo JA, Bunn PA Jr, Reynolds JC, Foon KA, Smarte NC, Ghosh B, Fejka RM, Larson SM, Mulshine JL (1987) Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma. Cancer Res 47(22):6093\u20136099","journal-title":"Cancer Res"},{"issue":"1","key":"328_CR21","first-page":"42","volume":"28","author":"AM Keenen","year":"1987","unstructured":"Keenen AM, Weinstein JN, Mulshine JL, Carrasquillo JA, Bunn PA Jr, Reynolds JC, Larson SM (1987) Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody. J Nucl Med 28(1):42\u201346","journal-title":"J Nucl Med"},{"issue":"11","key":"328_CR22","first-page":"1736","volume":"28","author":"RL Wahl","year":"1987","unstructured":"Wahl RL, Geatti O, Liebert M, Wilson B, Shreve P, Beers BA (1987) Kinetics of interstitially administered monoclonal antibodies for purposes of lymphoscintigraphy. J Nucl Med 28(11):1736\u20131744","journal-title":"J Nucl Med"},{"issue":"13","key":"328_CR23","first-page":"3572","volume":"47","author":"JL Mulshine","year":"1987","unstructured":"Mulshine JL, Keenan AM, Carrasquillo JA, Walsh T, Linnoila RI, Holton OD, Harwell J, Larson SM, Bunn PA, Weinstein JN (1987) Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging. Cancer Res 47(13):3572\u20133576","journal-title":"Cancer Res"},{"issue":"3 Suppl.","key":"328_CR24","first-page":"949s","volume":"50","author":"KJ Kairemo","year":"1990","unstructured":"Kairemo KJ (1990) Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431\/26) reacting with carcinoembryonic antigen in breast cancer. Cancer Res 50(3 suppl):949s\u2013954s","journal-title":"Cancer Res"},{"issue":"3","key":"328_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01146853","volume":"16","author":"HH Abdel-Nabi","year":"1990","unstructured":"Abdel-Nabi HH, Ortman-Nabi JA, See W, Lee J, Ireton R, Boileau M, Unger MW, Halverson C (1990) Clinical experience with intralymphatic administration of 111In-labeled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma. Eur J Nucl Med 16(3):149\u2013156","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"328_CR26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/108497803322285107","volume":"18","author":"MJ Blend","year":"2003","unstructured":"Blend MJ, Statstny JJ, Swanson SM, Brechbiel MW (2003) Labeling anti-HER2\/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent. Cancer Biother Radiopharm 18(3):355\u2013363","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"328_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nucmedbio.2004.08.003","volume":"32","author":"Y Tang","year":"2005","unstructured":"Tang Y, Wang J, Scollard DA, Mondal H, Holloway C, Kahn HJ, Reilly RM (2005) Imaging of HER2\/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments. Nucl Med Biol 32(1):51\u201358","journal-title":"Nucl Med Biol"},{"issue":"5","key":"328_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00006231-200505000-00006","volume":"26","author":"Y Tang","year":"2005","unstructured":"Tang Y, Scollard D, Chen P, Wang J, Holloway C, Reilly RM (2005) Imaging of HER2\/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments. Nucl Med Commun 26(5):427\u2013432","journal-title":"Nucl Med Commun"},{"issue":"4","key":"328_CR29","doi-asserted-by":"crossref","first-page":"041312","DOI":"10.1117\/1.2953498","volume":"13","author":"EM Sevick-Muraca","year":"2008","unstructured":"Sevick-Muraca EM, Wang W, Sampath L (2008) Near infrared fluorescent optical imaging for nodal staging. J Biomed Opt 13(4):041312","journal-title":"J Biomed Opt"},{"key":"328_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1413.002","volume":"1131","author":"EM Sevick-Muraca","year":"2008","unstructured":"Sevick-Muraca EM, Marshall MV, Adams KE, Rasmussen JC, Wendt JA, Sharma R (2008) New horizons for imaging lymphatic function. Ann N TY Acad Sci 1131:13\u201336","journal-title":"Ann N TY Acad Sci"},{"issue":"4","key":"328_CR31","doi-asserted-by":"crossref","first-page":"041303","DOI":"10.1117\/1.2953185","volume":"13","author":"JC Rasmussen","year":"2008","unstructured":"Rasmussen JC, Sevick-Muraca EM (2008) Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine. J Biomed Opt 13(4):041303","journal-title":"J Biomed Opt"},{"issue":"9","key":"328_CR32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2967\/jnumed.107.042234","volume":"48","author":"L Sampath","year":"2007","unstructured":"Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM (2007) Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 48(9):1501\u20131510","journal-title":"J Nucl Med"},{"key":"328_CR33","unstructured":"Guideline for validation of analytical procedures: text and methodology Q2(R1). Current step 4 version. Parent guideline dated 27 October 1994. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. http:\/\/www.ich.org\/LOB\/media\/MEDIA417.pdf"},{"key":"328_CR34","unstructured":"Guidance for industry, bioanalytical method validation. US Department of Health and Human Services FDA (CDER) and (CVM), May 2001. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM070107.pdf"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-010-0328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-010-0328-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-010-0328-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:36:23Z","timestamp":1559396183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-010-0328-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1007\/s11307-010-0328-7","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}